[Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].
Identifieur interne : 000178 ( Main/Exploration ); précédent : 000177; suivant : 000179[Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].
Auteurs : A. Amad [France] ; M. Magnat [France] ; C. Quilès [France] ; A. Yrondi [France] ; A. Sauvaget [France] ; S. Bulteau [France] ; M. Plaze [France] ; M. Rotharmel [France] ; M. Polosan [France] ; D. Lévy-Chavagnat [France] ; N. Jaafari [France] ; G. Vaiva [France] ; P. Thomas [France]Source :
- L'Encephale [ 0013-7006 ] ; 2020.
Descripteurs français
- KwdFr :
- Betacoronavirus (MeSH), Continuité des soins (MeSH), Contrôle des maladies transmissibles (MeSH), France (MeSH), Humains (MeSH), Hôpitaux psychiatriques (organisation et administration), Infections à coronavirus (MeSH), Pandémies (MeSH), Pneumopathie virale (MeSH), Prestations des soins de santé (MeSH), Trouble bipolaire (thérapie), Trouble dépressif (thérapie), Utilisation des procédures et des techniques (MeSH), Électroconvulsivothérapie (statistiques et données numériques), Électroconvulsivothérapie (tendances).
- MESH :
- organisation et administration : Hôpitaux psychiatriques.
- statistiques et données numériques : Électroconvulsivothérapie.
- tendances : Électroconvulsivothérapie.
- thérapie : Trouble bipolaire, Trouble dépressif.
- Betacoronavirus, Continuité des soins, Contrôle des maladies transmissibles, France, Humains, Infections à coronavirus, Pandémies, Pneumopathie virale, Prestations des soins de santé, Utilisation des procédures et des techniques.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Betacoronavirus (MeSH), Bipolar Disorder (therapy), Communicable Disease Control (MeSH), Continuity of Patient Care (MeSH), Coronavirus Infections (MeSH), Delivery of Health Care (MeSH), Depressive Disorder (therapy), Electroconvulsive Therapy (statistics & numerical data), Electroconvulsive Therapy (trends), France (MeSH), Hospitals, Psychiatric (organization & administration), Humans (MeSH), Pandemics (MeSH), Pneumonia, Viral (MeSH), Procedures and Techniques Utilization (MeSH).
- MESH :
- geographic : France.
- organization & administration : Hospitals, Psychiatric.
- statistics & numerical data : Electroconvulsive Therapy.
- therapy : Bipolar Disorder, Depressive Disorder.
- trends : Electroconvulsive Therapy.
- Betacoronavirus, Communicable Disease Control, Continuity of Patient Care, Coronavirus Infections, Delivery of Health Care, Humans, Pandemics, Pneumonia, Viral, Procedures and Techniques Utilization.
Abstract
The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from all over France were analysed. More than 90 % of the centres practising ECT experienced a decrease in their activity. Half of the centres experienced a total cessation of activity and 25 % of the centres experienced a decrease of more than half of their usual activity. Post-pandemic COVID-19 psychiatric care is expected to be difficult. It is essential not to add to this difficulty the complications, often serious, that will be associated with delaying or stopping the practice of ECT. It will also be necessary to remain vigilant with regard to the specific neuropsychiatric consequences that will follow the pandemic.
DOI: 10.1016/j.encep.2020.04.004
PubMed: 32370981
PubMed Central: PMC7174183
Affiliations:
- France
- Aquitaine, Auvergne-Rhône-Alpes, Hauts-de-France, Midi-Pyrénées, Nord-Pas-de-Calais, Nouvelle-Aquitaine, Occitanie (région administrative), Pays de la Loire, Poitou-Charentes, Rhône-Alpes, Île-de-France
- Bordeaux, Grenoble, Lille, Nantes, Paris, Poitiers, Toulouse
- Université Grenoble-Alpes, Université de Poitiers
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].</title><author><name sortKey="Amad, A" sort="Amad, A" uniqKey="Amad A" first="A" last="Amad">A. Amad</name><affiliation wicri:level="3"><nlm:affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France. Electronic address: ali.amad@chru-lille.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Magnat, M" sort="Magnat, M" uniqKey="Magnat M" first="M" last="Magnat">M. Magnat</name><affiliation wicri:level="3"><nlm:affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Quiles, C" sort="Quiles, C" uniqKey="Quiles C" first="C" last="Quilès">C. Quilès</name><affiliation wicri:level="3"><nlm:affiliation>Centre hospitalier Charles-Perrens, 33000 Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre hospitalier Charles-Perrens, 33000 Bordeaux</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Yrondi, A" sort="Yrondi, A" uniqKey="Yrondi A" first="A" last="Yrondi">A. Yrondi</name><affiliation wicri:level="3"><nlm:affiliation>Service de Psychiatrie et de Psychologie Médicale, Centre Expert Dépression Résistante FondaMental, CHU de Toulouse, Hôpital Purpan,ToNIC Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Psychiatrie et de Psychologie Médicale, Centre Expert Dépression Résistante FondaMental, CHU de Toulouse, Hôpital Purpan,ToNIC Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Sauvaget, A" sort="Sauvaget, A" uniqKey="Sauvaget A" first="A" last="Sauvaget">A. Sauvaget</name><affiliation wicri:level="3"><nlm:affiliation>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Bulteau, S" sort="Bulteau, S" uniqKey="Bulteau S" first="S" last="Bulteau">S. Bulteau</name><affiliation wicri:level="3"><nlm:affiliation>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Plaze, M" sort="Plaze, M" uniqKey="Plaze M" first="M" last="Plaze">M. Plaze</name><affiliation wicri:level="3"><nlm:affiliation>Université de Paris, 75005 Paris, France; Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, 75014 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Paris, 75005 Paris, France; Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, 75014 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Rotharmel, M" sort="Rotharmel, M" uniqKey="Rotharmel M" first="M" last="Rotharmel">M. Rotharmel</name><affiliation wicri:level="1"><nlm:affiliation>Service Hospitalo-Universitaire-Unité START, Centre Hospitalier du Rouvray, Sotteville-lès-Rouen, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service Hospitalo-Universitaire-Unité START, Centre Hospitalier du Rouvray, Sotteville-lès-Rouen</wicri:regionArea><wicri:noRegion>Sotteville-lès-Rouen</wicri:noRegion><wicri:noRegion>Sotteville-lès-Rouen</wicri:noRegion></affiliation></author><author><name sortKey="Polosan, M" sort="Polosan, M" uniqKey="Polosan M" first="M" last="Polosan">M. Polosan</name><affiliation wicri:level="4"><nlm:affiliation>Université Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, GIN, 38000 Grenoble, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, GIN, 38000 Grenoble</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Grenoble</settlement></placeName><orgName type="university">Université Grenoble-Alpes</orgName></affiliation></author><author><name sortKey="Levy Chavagnat, D" sort="Levy Chavagnat, D" uniqKey="Levy Chavagnat D" first="D" last="Lévy-Chavagnat">D. Lévy-Chavagnat</name><affiliation wicri:level="4"><nlm:affiliation>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Poitou-Charentes</region><settlement type="city">Poitiers</settlement></placeName><orgName type="university">Université de Poitiers</orgName></affiliation></author><author><name sortKey="Jaafari, N" sort="Jaafari, N" uniqKey="Jaafari N" first="N" last="Jaafari">N. Jaafari</name><affiliation wicri:level="4"><nlm:affiliation>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Poitou-Charentes</region><settlement type="city">Poitiers</settlement></placeName><orgName type="university">Université de Poitiers</orgName></affiliation></author><author><name sortKey="Vaiva, G" sort="Vaiva, G" uniqKey="Vaiva G" first="G" last="Vaiva">G. Vaiva</name><affiliation wicri:level="3"><nlm:affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Thomas, P" sort="Thomas, P" uniqKey="Thomas P" first="P" last="Thomas">P. Thomas</name><affiliation wicri:level="3"><nlm:affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32370981</idno><idno type="pmid">32370981</idno><idno type="doi">10.1016/j.encep.2020.04.004</idno><idno type="pmc">PMC7174183</idno><idno type="wicri:Area/Main/Corpus">001448</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001448</idno><idno type="wicri:Area/Main/Curation">001448</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001448</idno><idno type="wicri:Area/Main/Exploration">001448</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].</title><author><name sortKey="Amad, A" sort="Amad, A" uniqKey="Amad A" first="A" last="Amad">A. Amad</name><affiliation wicri:level="3"><nlm:affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France. Electronic address: ali.amad@chru-lille.fr.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Magnat, M" sort="Magnat, M" uniqKey="Magnat M" first="M" last="Magnat">M. Magnat</name><affiliation wicri:level="3"><nlm:affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Quiles, C" sort="Quiles, C" uniqKey="Quiles C" first="C" last="Quilès">C. Quilès</name><affiliation wicri:level="3"><nlm:affiliation>Centre hospitalier Charles-Perrens, 33000 Bordeaux, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Centre hospitalier Charles-Perrens, 33000 Bordeaux</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Aquitaine</region><settlement type="city">Bordeaux</settlement></placeName></affiliation></author><author><name sortKey="Yrondi, A" sort="Yrondi, A" uniqKey="Yrondi A" first="A" last="Yrondi">A. Yrondi</name><affiliation wicri:level="3"><nlm:affiliation>Service de Psychiatrie et de Psychologie Médicale, Centre Expert Dépression Résistante FondaMental, CHU de Toulouse, Hôpital Purpan,ToNIC Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service de Psychiatrie et de Psychologie Médicale, Centre Expert Dépression Résistante FondaMental, CHU de Toulouse, Hôpital Purpan,ToNIC Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse</wicri:regionArea><placeName><region type="region">Occitanie (région administrative)</region><region type="old region">Midi-Pyrénées</region><settlement type="city">Toulouse</settlement></placeName></affiliation></author><author><name sortKey="Sauvaget, A" sort="Sauvaget, A" uniqKey="Sauvaget A" first="A" last="Sauvaget">A. Sauvaget</name><affiliation wicri:level="3"><nlm:affiliation>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Bulteau, S" sort="Bulteau, S" uniqKey="Bulteau S" first="S" last="Bulteau">S. Bulteau</name><affiliation wicri:level="3"><nlm:affiliation>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes</wicri:regionArea><placeName><region type="region">Pays de la Loire</region><region type="old region">Pays de la Loire</region><settlement type="city">Nantes</settlement></placeName></affiliation></author><author><name sortKey="Plaze, M" sort="Plaze, M" uniqKey="Plaze M" first="M" last="Plaze">M. Plaze</name><affiliation wicri:level="3"><nlm:affiliation>Université de Paris, 75005 Paris, France; Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, 75014 Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Paris, 75005 Paris, France; Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, 75014 Paris</wicri:regionArea><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Rotharmel, M" sort="Rotharmel, M" uniqKey="Rotharmel M" first="M" last="Rotharmel">M. Rotharmel</name><affiliation wicri:level="1"><nlm:affiliation>Service Hospitalo-Universitaire-Unité START, Centre Hospitalier du Rouvray, Sotteville-lès-Rouen, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Service Hospitalo-Universitaire-Unité START, Centre Hospitalier du Rouvray, Sotteville-lès-Rouen</wicri:regionArea><wicri:noRegion>Sotteville-lès-Rouen</wicri:noRegion><wicri:noRegion>Sotteville-lès-Rouen</wicri:noRegion></affiliation></author><author><name sortKey="Polosan, M" sort="Polosan, M" uniqKey="Polosan M" first="M" last="Polosan">M. Polosan</name><affiliation wicri:level="4"><nlm:affiliation>Université Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, GIN, 38000 Grenoble, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, GIN, 38000 Grenoble</wicri:regionArea><placeName><region type="region" nuts="2">Auvergne-Rhône-Alpes</region><region type="old region" nuts="2">Rhône-Alpes</region><settlement type="city">Grenoble</settlement></placeName><orgName type="university">Université Grenoble-Alpes</orgName></affiliation></author><author><name sortKey="Levy Chavagnat, D" sort="Levy Chavagnat, D" uniqKey="Levy Chavagnat D" first="D" last="Lévy-Chavagnat">D. Lévy-Chavagnat</name><affiliation wicri:level="4"><nlm:affiliation>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Poitou-Charentes</region><settlement type="city">Poitiers</settlement></placeName><orgName type="university">Université de Poitiers</orgName></affiliation></author><author><name sortKey="Jaafari, N" sort="Jaafari, N" uniqKey="Jaafari N" first="N" last="Jaafari">N. Jaafari</name><affiliation wicri:level="4"><nlm:affiliation>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex</wicri:regionArea><placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region><region type="old region" nuts="2">Poitou-Charentes</region><settlement type="city">Poitiers</settlement></placeName><orgName type="university">Université de Poitiers</orgName></affiliation></author><author><name sortKey="Vaiva, G" sort="Vaiva, G" uniqKey="Vaiva G" first="G" last="Vaiva">G. Vaiva</name><affiliation wicri:level="3"><nlm:affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Thomas, P" sort="Thomas, P" uniqKey="Thomas P" first="P" last="Thomas">P. Thomas</name><affiliation wicri:level="3"><nlm:affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille</wicri:regionArea><placeName><region type="region" nuts="2">Hauts-de-France</region><region type="old region" nuts="2">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author></analytic><series><title level="j">L'Encephale</title><idno type="ISSN">0013-7006</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (MeSH)</term><term>Bipolar Disorder (therapy)</term><term>Communicable Disease Control (MeSH)</term><term>Continuity of Patient Care (MeSH)</term><term>Coronavirus Infections (MeSH)</term><term>Delivery of Health Care (MeSH)</term><term>Depressive Disorder (therapy)</term><term>Electroconvulsive Therapy (statistics & numerical data)</term><term>Electroconvulsive Therapy (trends)</term><term>France (MeSH)</term><term>Hospitals, Psychiatric (organization & administration)</term><term>Humans (MeSH)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (MeSH)</term><term>Procedures and Techniques Utilization (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (MeSH)</term><term>Continuité des soins (MeSH)</term><term>Contrôle des maladies transmissibles (MeSH)</term><term>France (MeSH)</term><term>Humains (MeSH)</term><term>Hôpitaux psychiatriques (organisation et administration)</term><term>Infections à coronavirus (MeSH)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (MeSH)</term><term>Prestations des soins de santé (MeSH)</term><term>Trouble bipolaire (thérapie)</term><term>Trouble dépressif (thérapie)</term><term>Utilisation des procédures et des techniques (MeSH)</term><term>Électroconvulsivothérapie (statistiques et données numériques)</term><term>Électroconvulsivothérapie (tendances)</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Hôpitaux psychiatriques</term></keywords><keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Hospitals, Psychiatric</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Electroconvulsive Therapy</term></keywords><keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Électroconvulsivothérapie</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Électroconvulsivothérapie</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Bipolar Disorder</term><term>Depressive Disorder</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Trouble bipolaire</term><term>Trouble dépressif</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Electroconvulsive Therapy</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Betacoronavirus</term><term>Communicable Disease Control</term><term>Continuity of Patient Care</term><term>Coronavirus Infections</term><term>Delivery of Health Care</term><term>Humans</term><term>Pandemics</term><term>Pneumonia, Viral</term><term>Procedures and Techniques Utilization</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Betacoronavirus</term><term>Continuité des soins</term><term>Contrôle des maladies transmissibles</term><term>France</term><term>Humains</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Prestations des soins de santé</term><term>Utilisation des procédures et des techniques</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from all over France were analysed. More than 90 % of the centres practising ECT experienced a decrease in their activity. Half of the centres experienced a total cessation of activity and 25 % of the centres experienced a decrease of more than half of their usual activity. Post-pandemic COVID-19 psychiatric care is expected to be difficult. It is essential not to add to this difficulty the complications, often serious, that will be associated with delaying or stopping the practice of ECT. It will also be necessary to remain vigilant with regard to the specific neuropsychiatric consequences that will follow the pandemic.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32370981</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>13</Day></DateCompleted><DateRevised><Year>2020</Year><Month>07</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0013-7006</ISSN><JournalIssue CitedMedium="Internet"><Volume>46</Volume><Issue>3S</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>L'Encephale</Title><ISOAbbreviation>Encephale</ISOAbbreviation></Journal><ArticleTitle>[Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].</ArticleTitle><Pagination><MedlinePgn>S40-S42</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0013-7006(20)30072-5</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.encep.2020.04.004</ELocationID><Abstract><AbstractText>The recent COVID-19 pandemic has led to major organisational changes in health care settings, especially in psychiatric hospitals. We conducted a national online survey to assess the evolution of electroconvulsive therapy (ECT) in the different centres practicing this treatment. 65 responses from all over France were analysed. More than 90 % of the centres practising ECT experienced a decrease in their activity. Half of the centres experienced a total cessation of activity and 25 % of the centres experienced a decrease of more than half of their usual activity. Post-pandemic COVID-19 psychiatric care is expected to be difficult. It is essential not to add to this difficulty the complications, often serious, that will be associated with delaying or stopping the practice of ECT. It will also be necessary to remain vigilant with regard to the specific neuropsychiatric consequences that will follow the pandemic.</AbstractText><CopyrightInformation>Copyright © 2020 L'Encéphale, Paris. Published by Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Amad</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France. Electronic address: ali.amad@chru-lille.fr.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magnat</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quilès</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre hospitalier Charles-Perrens, 33000 Bordeaux, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yrondi</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de Psychiatrie et de Psychologie Médicale, Centre Expert Dépression Résistante FondaMental, CHU de Toulouse, Hôpital Purpan,ToNIC Toulouse NeuroImaging Center, Université de Toulouse, INSERM, UPS, Toulouse, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauvaget</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bulteau</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Nantes Université, CHU Nantes,Movement, Interactions, Performance (MIP), EA 4334, University of Nantes, Nantes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Plaze</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Université de Paris, 75005 Paris, France; Service Hospitalo-Universitaire, GHU Paris Psychiatrie & Neurosciences, 75014 Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rotharmel</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service Hospitalo-Universitaire-Unité START, Centre Hospitalier du Rouvray, Sotteville-lès-Rouen, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polosan</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Université Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, GIN, 38000 Grenoble, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lévy-Chavagnat</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaafari</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Unité de recherche clinique, université de Poitiers, centre hospitalier Henri-Laborit, 370, avenue Jacques-Cœur, CS10587, 86021 Poitiers cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaiva</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thomas</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Université de Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience & Cognition, 59000 Lille, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>fre</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Évolution de l’activité d’électro-convulsivo-thérapie en France depuis le début de la pandémie COVID-19.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Encephale</MedlineTA><NlmUniqueID>7505643</NlmUniqueID><ISSNLinking>0013-7006</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001714" MajorTopicYN="N">Bipolar Disorder</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003266" MajorTopicYN="N">Continuity of Patient Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="Y">Coronavirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003695" MajorTopicYN="N">Delivery of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003866" MajorTopicYN="N">Depressive Disorder</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004565" MajorTopicYN="N">Electroconvulsive Therapy</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName><QualifierName UI="Q000639" MajorTopicYN="Y">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006778" MajorTopicYN="N">Hospitals, Psychiatric</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="Y">Pneumonia, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000078337" MajorTopicYN="N">Procedures and Techniques Utilization</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Accès aux soins</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Complications</Keyword><Keyword MajorTopicYN="N">Electroconvulsive therapy</Keyword><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Health care access</Keyword><Keyword MajorTopicYN="N">Pandémie</Keyword><Keyword MajorTopicYN="N">Électro-convulsivo-thérapie</Keyword><Keyword MajorTopicYN="N">Épidémiologie</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>09</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32370981</ArticleId><ArticleId IdType="pii">S0013-7006(20)30072-5</ArticleId><ArticleId IdType="doi">10.1016/j.encep.2020.04.004</ArticleId><ArticleId IdType="pmc">PMC7174183</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Aquitaine</li><li>Auvergne-Rhône-Alpes</li><li>Hauts-de-France</li><li>Midi-Pyrénées</li><li>Nord-Pas-de-Calais</li><li>Nouvelle-Aquitaine</li><li>Occitanie (région administrative)</li><li>Pays de la Loire</li><li>Poitou-Charentes</li><li>Rhône-Alpes</li><li>Île-de-France</li></region><settlement><li>Bordeaux</li><li>Grenoble</li><li>Lille</li><li>Nantes</li><li>Paris</li><li>Poitiers</li><li>Toulouse</li></settlement><orgName><li>Université Grenoble-Alpes</li><li>Université de Poitiers</li></orgName></list><tree><country name="France"><region name="Hauts-de-France"><name sortKey="Amad, A" sort="Amad, A" uniqKey="Amad A" first="A" last="Amad">A. Amad</name></region><name sortKey="Bulteau, S" sort="Bulteau, S" uniqKey="Bulteau S" first="S" last="Bulteau">S. Bulteau</name><name sortKey="Jaafari, N" sort="Jaafari, N" uniqKey="Jaafari N" first="N" last="Jaafari">N. Jaafari</name><name sortKey="Levy Chavagnat, D" sort="Levy Chavagnat, D" uniqKey="Levy Chavagnat D" first="D" last="Lévy-Chavagnat">D. Lévy-Chavagnat</name><name sortKey="Magnat, M" sort="Magnat, M" uniqKey="Magnat M" first="M" last="Magnat">M. Magnat</name><name sortKey="Plaze, M" sort="Plaze, M" uniqKey="Plaze M" first="M" last="Plaze">M. Plaze</name><name sortKey="Polosan, M" sort="Polosan, M" uniqKey="Polosan M" first="M" last="Polosan">M. Polosan</name><name sortKey="Quiles, C" sort="Quiles, C" uniqKey="Quiles C" first="C" last="Quilès">C. Quilès</name><name sortKey="Rotharmel, M" sort="Rotharmel, M" uniqKey="Rotharmel M" first="M" last="Rotharmel">M. Rotharmel</name><name sortKey="Sauvaget, A" sort="Sauvaget, A" uniqKey="Sauvaget A" first="A" last="Sauvaget">A. Sauvaget</name><name sortKey="Thomas, P" sort="Thomas, P" uniqKey="Thomas P" first="P" last="Thomas">P. Thomas</name><name sortKey="Vaiva, G" sort="Vaiva, G" uniqKey="Vaiva G" first="G" last="Vaiva">G. Vaiva</name><name sortKey="Yrondi, A" sort="Yrondi, A" uniqKey="Yrondi A" first="A" last="Yrondi">A. Yrondi</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000178 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000178 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32370981
|texte= [Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32370981" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |